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Effects of nifedipine on the peri-operative
ECG, as determined by continuous
Holter monitoring
A double-blind study
H. J. DU TOIT, H. F. H. WElCH, H. W. WEYMAR, J. Z. PRZYBOJEWSKI
Summary
A double-blind study was performed on 50 elderly
patients undergoing hip-replacement surgery under
general anaesthesia; 26 were given nifedipine and
the remaining 24 placebo to determine effects on the
continuously monitored (Holter) ECG during the 4
peri-operative days. Drugs were only administered
during the latter 3 days of the observation period.
Surgery was performed on the morning of the 3rd
day.
A striking feature was the high incidence of
arrhythmias in both groups of patients, a finding
previously documented in both 'normal' and elderly
people. A decrease in ST-segment changes was
expected in the nifedipine-treated patients. An unex-
pected finding, therefore, was the lack of protection
against cardiac ischaemic changes in the nifedi-
pine-treated patients compared with the placebo
patients.
Interpretation of the ST segment as seen in the
Holter-monitored ECG remains controversial. We
have no clear explanation for the lack of protection
against ischaemic changes. The effects of profound
vasodilatation produced by nifedipine in elderly
patients subjected to major surgery, general anaes-
thesia including administration of enflurane, and a
variable amount of blood loss in the postoperative
period may be important factors. In conclusion, one
should perhaps be cautious of nifedipine administra-
tion under these circumstances.
S Atr Med J 1986; 69: 427-431.
and theoretical limitations of early recording and analysis
equipment were stressed by Hinkle er a/. 2 The advantage of
24-hour continuous ECG monitoring was demonstrated by
Lopes er al.;3 improved apparatus can record for 48 hours,4
but for practical purposes 24-hour monitoring of ambulatory
patients is that most widely used.
In the present study it was decided to evaluate the electro-
physiological effects of nifedipine on the heart in a double-
blind trial on elderly patients scheduled for total hip replace-
ment under general anaesthesia. The patients were continuously
monitored by Holter ECG for the 4 peri-operative days,
including during the operation. The 1st day served as a control
period and from the 2nd day onwards either nifedipine or
placebo was administered sublingually.
Patients and methods
A double-blind study was performed on 50 patients, 37 females
and 13 males with a mean age of 72 years (range 63 - 84 years). All
these patients were comparable from a cardiovascular point of
view (Table I). One patient in each group was receiving digoxin,
although there was no clinical evidence of cardiac failure at the
pre-operative visit. Twenty-six patients received oral nifedipine 10
mg 8-hourly for the latter 3 peri-operative days (surgery was
performed on the morning of the 3rd day); 24 patients received a
placebo and served as controls. The observation period was divided
into four time intervals with subdivisions as follows: time interval
I = the first 24 hours - no drug administration; time interval
11 = the second 24 hours - placebo or nifedipine commenced and
administered until end of trial; time interval III = the third 24
hours (a - operation, b - 6 hours postoperatively, c - remainder
of 24 hours); and time interval IV = the fourth 24 hours.
TABLE I. INCIDENCE OF CARDIOVASCULAR DISEASE IN
EACH GROUP
Over the last 2 decades ambulatory electrocardiography has
become an important tool in clinical cardiology. Continuous
ECG monitoring of active subjects has evolved from early
work by Holter. 1 Despite initial enthusiasm for the use of
ambulatory cardiography in the diagnosis of ischaemia, practical
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TABLE Ill. INCIDENCE OF HEART BLOCKS IN EACH GROUP
LBBB = left bundle-branch block; 10 AV = first degree atrioventricular block; RBBB
= right bundle-branch block; 1nl. 2:1 = intermittent 2:1 atrioventricular block; Pre-
op. = pre-operatively; Gp. and Postop. = intra-operatively and postoperatively.
recordings in each of me patient groups. Results for different
types of abnormalities will be analysed. Table III represents the
incidence of the various rypes of heart block occurring during the
pre-operative, operative and postoperative periods for bom groups.
Nifedipine did not alter me incidence of heartblock. In Table IV
the spectrum of ventricular arthythrnias in bom me nifedipine-
and placebo-treated patients is shown. Nifedipine had neimer
beneficial nor deleterious effects on the spectrum of ventricular
arrhyrhmias. The incidence of ST-segment changes in bom groups
of patients is shown in Table V. The expected beneficial effect of
nifedipine on ST-segment elevation or depression was not encoun-
tered.
Pre-op.
o
o
o
o
5
o
o
5
Pre-op.
2
2
1
1
o
o
o
6
Nifedipine (N = 26)
Op. and
postop.
2
2
1
1
o
o
o
6
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Op. and
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o
o
o
o
5
o
1
6
LBBB
LBBB and 1° AV
RBBB
RBBB and 1° AV
1° AV
1° AV and 1nl. 2:1
Int.2:1
Total
Anaesthetic management
Patients were given premedication wim pethidine hydrochloride
and promemazine hydrochloride, the former alone being favoured
for older patients. All patients were pre-oxygenated. Anaesmesia
was induced wim etomidate 0,15-0,2 mg/kg followed by pan-
curonium 0,1 mg/kg. The patients were ventilated with a fractional
inspired oxygen concentration (Fio2) of 0,4 in nitrous oxide. The
trachea was inmbated with a No. 8 or 9 cuffed endotracheal mbe.
Appropriate doses of fentanyl (0, I - 0,2 mg) and a low concentration
of enflurane « 1,0%) were used for maintenance of anaesmesia. A
Bird MK ll-Venrviva combination in a closed circuit, incorporating
a warm-water humidifier, was used for ventilation. At me end of
the operation curarization was reversed wim atropine and prostig-
mine.
The mean anaesmetic and operative times for me nifedipine
group were 163 ± 6 minutes and 112 ± 4 minutes respectively.
For me control group me times were 160 ± 5 minutes and III ±
5 minutes respectively. Postoperatively me patients were exposed
to an Fio2 of 0,4 for 24 hours using a face mask. The blood
pressure and pulse rate were meticulously observed. All anaes-
metics were administered by one of us (H. J. du T).
During me operation arterial pressure, central venous pressure
(CVP), expiratory carbon dioxide concentration, ECG, inspired
oxygen concentration, oesophageal temperature, blood gases and
electrolytes were monitored; all were wimin me normal range.
The mean intra-operative blood loss in the nifedipine- and
placebo-treated patients was comparable (852 ± 52 ml and 819 ±
57 ml respectively).
Because of the vasodilatation produced by nifedipine and the
memylmemacrylate (bone cement)5 used, CVP monitoring was
mandatory to prevent a fall in blood volume. CVP readings were
kept at about 15 cm H 20 throughout me operation by me infusion
of crystalloid solutions or blood.
Holter recordings
After careful skin preparation, five disposable electrodes were
used to attach me leads to me chest. Two bipolar monitoring leads
were used, i.e. VS and aVF. Wim these two leads both anterolateral
and inferior ST-segment changes could be observed.6 Oxford
Medilog 4-24 AM recorders were used. These recorders were
updated to MR-14 models with a frequency response of 0,08 - 70
Hz in order to register more reliable ST-segment changes man
obtainable with the standard recorders. The Oxford Replay Unit
was used for playing back me tapes. The final analysis was cartied
out by H.F.H.W., H.W. and J.Z.P.
Results
Table II shows me overall incidence of ECG changes on Holter
Discussion
Cardiovascular effects of nifedipine
Nifedipine causes dilatation of virtually all anerial beds with
me coronary, cerebral and skeletal systems being the most
sensitive.7 Effects on veins are less well characterized. 8- 1O In in
vilTo studies nifedipine exerts negative inotropic and chrono-
tropic effects on the hean. 11- IJ In in vivo experiments in
animal and man the effects of nifedipine on the hean are those
of positive chronotropism and inotropism. This disparity be-
tween the in vilTo and in vivo results has led to the idea that
the cardiac actions of nifedipine observed in animal and man
are baroreceptor reflex-mediated in response to the decrease in
total peripheral resistance."·12.14.15 However, despite the increase
TABLE 11. INCIDENCE OF ECG CHANGES ON HOLTER RECORDINGS IN EACH GROUP
Time Sinus tachy. Sinus brady. PAT ST. STt
intervals Group > 120/min < SO/min > 120/min PVC 2 - S mm >Smm 2 - S mm >Smm
~ : 2 6 5 12 1 0 1 05 3 7 16 3 0 2 1
~: 3 2 4 12 0 0 0 111 1 2 7 13 2 0 2 1
~: 2 4 1 9 1 0 2 0ilia 2 3 3 11 5 0 2 1
~: 2 3 3 6 0 0 1 0IIIb 1 2 2 12 3 0 1 0
lIIe ~ : 2 0 3 3 1 0 1 00 0 5 5 4 0 2 0
IV ~: 4 0 5 10 2 0 1 02 1 9 13 2 1 1 0
Tachy_ = tachycardia; brady. = bradycardia; PAT = paroxysmal atrial tachycardia; PVC = premature ventricular contractions; ST. = ST-segment depression; STt = ST-segment
elevation; P = placebo; N = nifedipine.
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TABLE IV. SPECTRUM OF VENTRICULAR ARRHYTHMIAS IN EACH GROUP*
Time < 30 PVC/h > 30 PVC/h Multiform Coupling VT Ron T Total
intervals Group (Lown I) (Lown 11) (Lown Ill) (Lown IVa) (Lown IVb) (Lown V) Bigeminy Trigeminy episodes
I ~ ~ 8 1 0 2 1 0 4 0 166 2 3 2 2 1 3 4 23
11 ~~ 8 0 0 3 1 0 1 1 148 0 0 3 2 0 2 3 18
ilia ~~ 5 1 0 2 1 0 1 2 126 1 0 3 1 0 1 1 13
IIIb 1~ 2 1 2 1 0 0 0 0 64 1 4 3 0 0 5 0 17
lIIe ~~ 1 0 0 2 0 0 1 1 51 2 0 1 1 1 0 1 7
IV ~~ 6 0 0 3 1 0 1 3 146 2 1 1 3 1 2 1 17
Total ~~ 30 3 2 13 4 0 8 7 6731 8 8 13 9 3 13 10 95
*Thirty-nine patients were involved. 20 in the placebo (P) group and 19 in the nifedipine {N} group.
PVC =: premature ventricular contractions; VT = ventricular tachycardia.
TABLE V. INCIDENCE OF ST-SEGMENT CHANGES IN BOTH GROUPS
Time sn STt
intervals Group 2-3 mm 4-5 mm > 5 mm Total 2-3 mm 4-5 mm > 5 mm Total
~ ~ 1 0 0 1 0 1 0 13 0 0 3 2 0 1 3
11 ~ ~ 0 0 0 0 0 0 1 12 0 0 2 2 0 1 3
ilia ~ ~ 1 0 0 1 0 2 0 22 3 0 5 1 1 1 3
IlIb ~~ 0 0 0 0 0 1 0 13 0 0 3 1 0 0 1
IIle ~~ 0 1 0 1 0 1 0 14 0 0 4 1 1 0 2
IV ~~ 2 0 0 2 0 1 0 12 0 1 3 0 1 0 1
Total ~ ~ 4 1 0 5 0 6 1 716 3 1 20 7 3 3 13
sn = ST-segment depression (12 patients were involved, 4 in the placebo (P) group and 8 in the nifedipine (N) group);
STt = ST-segment elevation (6 patients were involved, 2 in the P group and 4 in the N group).
9
in cardiac function demonstrated in animal and man, the
reduction in afterload, with a possible direct drur. effect,
causes a net reduction in myocardial oxygen demand. 1 ,15-17
The ECG of the elderly person
Table VI lists some of the arrhythmias observed in elderly
patients by Glasser er a!., 18 Camm er a!. 19 and Gomes er al. 20
Our figures were derived from all patients during the 24-hour
control period (no drugs were administered). The high inci-
dence of arrhythmias in 'normal' elderly patients indicates that
care should be taken when analysing results, especially when
trial drugs are involved.
Ventricular arrhythmias
Ventricular arrhythmias are common in young healthy per-
sons with no heart disease;21 the prevalence increases with age
and also in persons with heart disease. 22 Cohen er al. 23 have
demonstrated in in virro experiments that nifedipine has a
minor effect on cardiac conductive tissue, hence the finding
that nifedipine did not influence the incidence of conduction
disturbances in our patients (Table Ill) was not unexpected.
Holter monitoring for the detection of
myocardial ischaemia
Bragg-Remschel er al. 24 examined the reproducibility of a
standard ST-segment shift using equipment from eight manu-
facturers, and concluded that although some manufacturers'
equipment faithfully reproduced simulated ST-segment
depression, others did not. More recently, improvements in
tape-replay techniques have greatly increased the reliability of
ST-segment analysis.2s- 27 Using Avionics (Model 350 E and
400) tape-recorders Stem er al. 28 found good correlation be-
tween ambulatory ECG monitoring and coronary arteriograms
and concluded ,"'It l-Iolter monitoring was a reliable tool for
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TABLE VI. COMPARATIVE INCIDENCES OF ARRHYTHMIAS IN ELDERLY SUBJECTS
Age of
patients No. of %VPC
(yrs) patients % PAT > 30/h % Multi. % Coupling %VT % Bigem.
Glasser et al. '8 60-84 13 54 15 77 (no distinction made in these arrhythmias)
Camm et al.' 9 _ 75 106 3 26 22 6 4 5
Gomes et al.2o 60 ± 10 73 8,2 4,1 50,7
Present study 63-84 50 24 10 16 14 4 8
PAT = paroxysmal atrial tacfiycardia; VPC = ventricular premature contractions; Multi. = multiform; VT = ventricular tachycardia; Bigem. =bigeminy.
diagnosing ischaemic heart disease provided the correct equip-
ment was used.
Review of the current literature suggests that asymptomatic
ST-segment deviation (elevation and depression) must be
accepted as due to mlocardial ischaemia until proved to the
contrary29,30 Cohn31,L anributes this finding to a 'defective
anginal warning system' that might reflect 'silent myocardial
ischaemia', and this is more likely to be present with increasing
age.
Analysis of ST-segment deviation in our study highlighted
some interesting facts. The anticipated decrease in ST-segment
depression or elevation was not achieved by the administration
of nifedipine (Table V). Although the data in Table V cannot
be subjected to rigid statistical analysis, certain trends do
become apparent. It will be noticed that there is a 3: I ratio in
the incidence of ST-segment shifts in the patients allocated to
the nifedipine and placebo groups respectively during the first
24 hours of no drug administration (time interval I). Summa-
tion of the incidence of ST-segment depression at the comple-
tion of the trial demonstrated a ratio of 20:5 in the nifedipine
and placebo groups respectively, while the incidence of ST-
segment elevation occurred in a ratio of 13:7. When the
individual time intervals are analysed it becomes quite clear
that the nifedipine group experienced a higher incidence of
ST-segment deviation than the placebo group. An exception
in this trend was observed with 4 - 5 = ST-segment elevation,
where this ratio was 3:6. Furthermore, nifedipine did not
decrease the degree of ST-segment depression or elevation. In
fact, during the operative period (time interval IIIa in Table
V) the incidence of ST-segment depression was in a ratio of
5: 1 in the nifedipine and placebo groups respectively. If it is
accepted that both ST-segment depression and elevation may
reflect 'silent myocardial ischaemia', it becomes justifiable to
pool the patients. In that case it is possible to pool the data
and conclude as follows: total number of ST deviations - 45;
number of ST deviations with placebo - 12; and number of
ST deviations with nifedipine - 33.
Utilizing a chi-square test gives a highly significant result
(P < 0,005), indicating that under conditions of total hip re-
placement with general anaesthesia including enflurane,
patients who receive nifedipine have a much higher incidence
of ST-segment deviation than the placebo group.
Conclusion
The results of the trial are enlightening. Nifedipine did not
afford the protection, with reference to ST-segment changes,
that was expected; on the contrary, patients given nifedipine
had a statistically significant increase in ST-segment deviation
over the placebo group. As there is no previous reference to
the use of nifedipine with extensive ECG monitoring during
enflurane anaesthesia, the possibility exists that this inhalational
anaesthetic agent with its cardiodepressant effects33 combined
with nifedipine therapy may be responsible for our results.
The summary of Kates and Kaplan34 on the haemodynamic
interactions of calcium blockers and inhalational anaesthetic
agents is very apt: 'Like the channel blocking drugs, the net
hemodynamic effects of the anesthetic agents in the intact
animal and humans are a complex interaction of the direct
tissue effects and the consequences of drug-induced changes
in preload; afterload, cardiac rhythm and the autonomic tone
on the cardiovascular system.'
Our results indicate that enflurane and nifedipine are not
incompatible when major surgery is performed, but there is an
indication for caution in the handling of patients receiving
these agents.
Our thanks to the Chief Medical Superintendent of Tygerberg
Hospital for permission to publish and Mrs S. Venter for ryping
the MS. The research was financed by Messrs Bayer-Miles (Pry)
Ltd and the South African Medical Research Council.
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A new povidone-iodine
treatment of burns
cream for the
Comparison with a standard topical regimen
M. DE KOCK, A. E. VAN DER MERWE, F. C. HOUGHTON
"
Summary
A remarkable improvement in the rate of bum healing
has been achieved with a mixture of povidone-
iodine ointment (Betadine) and malic, benzoic and
salicylic acids (MBS) (Aserbine). A study was under-
taken to compare the effects of a new povidone-
iodine formulation (Betadine cream) with and without
MBS with povidone-iOdine ointment plus MBS. All
preparations were easy to apply and were readily
removed, causing only mild discomfort on application
in the majority of cases.
A significant difference in healing times was ob-
served between povidone-iodine cream and
Burns Unit, Tygerberg Hospital, Parowvallei, CP
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povidone-iodine cream plus MBS. There was also a
significant difference in the decrease in the number
of positive bacterial cultures between these two treat-
ments. This applied to both superficial and deep
burns. No skin sensitivity reactions were reported
with any of the preparations.
The addition of MBS to povidone-iodine cream did
not produce as significant an improvement in results
as its addition to povidone-iodine ointment
S Air Med J 1986; 69: 431-435.
Much progress has been made in the last 15 years in the
management of patients with burns, especially in the treatment
of shock. Infection caused by the proliferation of pathogenic
organisms, chiefly bacteria and fungi, is the foremost problem
in treatment. It is important, therefore, to search for locally
applicable preparations capable of effectively disinfecting the
surface of the burnt area. The principal requirements of such a
preparation are that it is non-irritant, easily applied (i.e.
spreads well) and is without effect on acid-base balance. .
